Fundz

Intelligent Bio Solutions

NEW YORK, NY · Health Care, Medical · 135 employees

Intelligent Bio Solutions is on a mission to redefine the approach to testing and deliver pain-free, accessible solutions that drive transformative change and improve the quality of life.

Funding history

  • Venture - Series Unknown — $10.0M — Jan 2026
  • Post-IPO Equity — $10.0M — Jan 2026
  • Seed — $3.8M — Aug 2025
  • Venture - Series Unknown — $10.1M — Mar 2024

Recent signals

  • Jan 13, 2026: Raised $10.0M in Venture - Series Unknown
  • Jan 07, 2026: SEC 8-K (8.01): On January 7, 2026, Intelligent Bio Solutions Inc. received a letter from the Nasdaq Stock Market indicating that it had regained compliance with the minimum bid price requirement for continued inclusion on the Nasdaq Capital Market. This was in response to a prior deficiency letter received on December 16, 2025, due to the company's common stock closing bid price falling below $1.00 per share for 30 consecutive business days. The successful compliance notification allows the company to continue trading on Nasdaq, which is critical for maintaining investor confidence and market access.
  • Jan 02, 2026: Raised $10.0M in Post-IPO Equity
  • Oct 23, 2025: Intelligent Bio Solutions Secures Major UK Contract to Provide Rapid Drug Testing Technology.
  • Oct 16, 2025: SEC 8-K (5.02): On October 16, 2025, Intelligent Bio Solutions Inc. held its annual meeting where stockholders approved an amendment to the 2019 Long Term Incentive Plan, increasing the number of shares available for issuance from 1,300,000 to 1,795,000. This amendment allows the company to issue an additional 495,000 shares under the incentive plan, which may enhance employee compensation and retention strategies. The details of the plan, including the amendment, are outlined in the definitive proxy statement filed on September 19, 2025. This change is significant as it potentially impacts the company's ability to motivate and reward its management and key personnel.
  • Aug 11, 2025: Raised $3.8M in Seed
  • Jan 29, 2025: Quantum TM Adds Intelligent Fingerprinting Drug Testing Solution to 400+ Account Portfolio
  • Jan 28, 2025: Launched Intelligent Bio Solutions Inc. partners with IVY Diagnostics to enhance its Intelligent Fingerprinting Drug Testing Solution across Europe and the Middle East.

See plans & pricing → Track Intelligent Bio Solutions’s funding, hiring, and signals — with verified contacts — on Fundz.